doi:10.11852/zgetbjzz2015-23-07-16

Abstract

摘要： 哮喘是一种由遗传因素和一些环境因素相互作用导致的具有遗传倾向的复杂疾病,是儿童时期的常见病和多发病。近年来,随着哮喘遗传药理学的发展,遗传异质性对哮喘治疗的影响得到大家的关注。

关键词: 支气管哮喘, 白细胞介素-13, 基因多态性, 治疗

CLC Number:

R725.6

岳冬梅综述, 刘丽晓审校. 白介素-13基因多态性与儿童哮喘治疗的研究进展[J]. 中国儿童保健杂志, 2015, 23(7): 727-729.

0
/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://manu41.magtech.com.cn/Jwk_zgetbjzz/EN/10.11852/zgetbjzz2015-23-07-16

https://manu41.magtech.com.cn/Jwk_zgetbjzz/EN/Y2015/V23/I7/727

[1] 全国儿科哮喘协作组.中国儿童哮喘患病情况调查[N].中国医学论坛报,2006.4.27.
[2] Hopp RJ,Bewtra AK,Watt GD.Genetic analysis of allergic disease in twins[J].J Allergy Clin Immunol,1984,73:265-270.
[3] Prieto J,Lensmar C,Roquet A,et al.Increased interleukin-13 mRNA expression in bronchoalveolar lavage cells of atopic patients with mild asthma after repeated low-dose allergen provocations[J].Respir Med,2000,94:806-814.
[4] Konstantinidis AK,Barton SJ,Sayers I,et al.Genetic association studies of interleukin-13 receptor alpha1 subunit gene polymorphisms in asthma and atopy[J].Eur Respir J,2007,30:40-47.
[5] Pope SM,Brandt EB,Mishra A,et al.IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxindependent mechanism[J].J Allergy Clin Immunol,2001,108:594-601.
[6] Chibana K,Trudeau JB,Mustovich AT,et al.IL-13 induced increases in nitrite levels are primarily driven by increases in inducible nitric oxide synthase as compared with effects on arginases in human primary bronchial epithelial cells[J].Clin Exp Allergy,2008,38:936-946.
[7] Martinez-Nunez RT,Louafi F,Sanchez-Elsner T.The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1)[J].J Biol Chem,2011,286:1786-1794.
[8] Taussig LM,Wright AL,Holberg CJ,et al.Tucson children s spiratory study:1980 to present[J].J Allergy Clin Immunol,2003,111(4):661-675.
[9] 王长征.支气管哮喘表型[J].内科理论与实践,2011,6(2):102-105.
[10] Kurukulaaratchy RJ,Fenn MH,Waterhouse LM,et al.Characterization of wheezing phenotypes in the first 10years of life[J].Clin Exp Allergy,2003,33(5):573-578.
[11] Kelly C,Theresa WG.Pediatric asthma phenotypes[J].Curr Opin Pediatr,2012,24:344-351.
[12] 赵锰,赵京,戴耀华.哮喘基因进展[J].中华临床免疫和变态反应杂志,2009,3(2):122-127.
[13] Nie W,Liu YA,Bian JR,et al.Effects of polymorphisms-1112C/T and +2044A/G in interleukin-13 gene on asthma risk:a Meta-analysis[J].PloS One,2013,8(2):e56065.
[14] Micheal S,Minhas K,Ishaque M,et al.IL-13 Gene Polymorphisms and their association with atopic asthma and rhinitis in pakistani patients[J].Iran J Allergy Asthma Immunol,2013,12(4):391-396.
[15] Beghé B,Hall IP,Parker SG,et al.Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease[J].Allergy,2010,65:474-481.
[16] Gwan GS,Young HL.Pathway analysis of genome-wide association study on asthma[J].Human Immunology,2013,74(2):256-260.
[17] Hiromi N,Yutaka N,Hiroyuki K,et al.Effect of genetic variation of IL-13 on airway remodeling in bronchial asthma[J].Allergology International,2011,60:291-298.
[18] 谢莉,李艳,刘蓉,等.孟鲁司特钠治疗儿童咳嗽变异性哮喘 45 例疗效观察[J].药物与临床,2012,50(28):52-53.
[19] 楼英萍.孟鲁司特钠治疗儿童咳嗽变异性哮喘的疗效观察[J].海峡药学,2011,23(5):157-158.
[20] Gary MH,Manuel ES,Lydiana A,et al.Polymorphisms in IL13,total IgE,eosinophilia,and asthma exacerbations in childhood[J].J Allergy Clin Immunol,2007,120:84-90.
[21] Jonathan C,Robert FL,Nicola AH,et al.Lebrikizumab treatment in adults with asthma[J].N Engl J Med,2011,365:1088-1098.
[22] Jonathan C.Role of interleukin-13 in asthma[J].Curr Allergy Ashma Rep,2013,13(5):415-420.
[23] Piper E,Brightling C,Niven R,et al.A phase II placebocontrolled study of tralokinumab in moderate-to-severe asthma[J].European Respiratory,2013,41(2):330-338.
[24] Wechsler ME,Kunselman SJ,Chinchilli VM,et al.Effect of beta 2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial):a genotypestratified,randomised,placebo-controlled,crossover trial[J].Lancet,2009,374:1754-1764.
[25] Israel E,Chinchilli VM,Ford JG,et al.Use of regularly scheduled albuterol treatment in asthma:genotype-stratified,randomised,placebo-controlled cross-over trial[J].Lancet,2004,364:1505 -1512.
[26] Slager RE,Otulana BA,Hawkins GA,et al.IL-4 receptor polymorphisms predict reduction in asthma exacerbationsduring response to an anti-IL-4 receptor alpha antagonist[J].J Allergy Clin Immunol,2012,130:516 -522.

白介素-13基因多态性与儿童哮喘治疗的研究进展

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

[1]	YE Zhixu, YU Fuxun. Research progress of gut microbiota and respiratory virus infection in children [J]. Chinese Journal of Child Health Care, 2023, 31(7): 766-769.
[2]	LI Yu, ZHAO Jia-hong, KAN Xuan. Clinical application of China Children′s Asthma Action Plan [J]. Chinese Journal of Child Health Care, 2023, 31(2): 185-189.
[3]	WANG Xu, WANG Shu-ying, LI Li, ZOU Ying-xue. Meta-analysis of the risk factors for recurrent wheezing after bronchiolitis [J]. Chinese Journal of Child Health Care, 2023, 31(2): 190-194.
[4]	LI Yu, KAN Xuan. Research progress in the application of bacterial lysates in children with respiratory allergic diseases [J]. Chinese Journal of Child Health Care, 2022, 30(12): 1336-1340.
[5]	ZHANG Yang, WANG Hui-yuan, GENG Yan, JIN Qiao-yan, HAO Juan-juan, HOU Wei. Status quo and related factors of emotional problems in children with bronchial asthma [J]. Chinese Journal of Child Health Care, 2022, 30(12): 1400-1403.
[6]	YANG Li-juan, DENG Gao, DING Bo, YANG Li-min, LI Dong-ming, HUANG Yong-fang, LIN Na. Association of ADAM33 gene and its serum level with the risk of asthma in Zhuang children in Guangxi [J]. Chinese Journal of Child Health Care, 2022, 30(11): 1185-1190.
[7]	LI Wan-ying, SONG Chun-lan, SHAN Zhao-qian, XIONG Lei-lei, ZHANG Zhi-ying. Changes and significance of cardiovascular metabolic indicators in children with asthma at different control levels [J]. Chinese Journal of Child Health Care, 2022, 30(11): 1246-1249.
[8]	FU Yan-yan, LIU Wei, XU Li-yuan. Difference in air pollutant concentration between suburbs and urban areas and its correlation with the severity of asthma in children [J]. Chinese Journal of Child Health Care, 2022, 30(11): 1262-1266.
[9]	SHEN Ren, YANG Shan-pu, ZHANG Lin-tao, WU Yue-chao. Relationship between recurrent wheezing and gene prediction model of four-locus asthma in children and risk factors of recurrent wheezing [J]. Chinese Journal of Child Health Care, 2022, 30(10): 1132-1135.
[10]	XU Yan, LIU Dong-hai, LIANG Xuan, GUO Li, DAI Yong-li, ZHANG Rong-fang. Influencing factors of asthma in children from the plateau area [J]. Chinese Journal of Child Health Care, 2022, 30(7): 796-800.
[11]	HUI Xiao-jun, QI Yu-min, WANG Pin, CHEN Ke-yun, WANG Yan. Regulatory mechanism of hBD2 and ARGs genes on angiogenesis in children with bronchopulmonary dysplasia and its correlation with lung development markers [J]. Chinese Journal of Child Health Care, 2022, 30(3): 325-329.
[12]	HE Jia, LI Meng-qi, LI Xue-ning, LIU Ying. Related factors of recurrent respiratory tract infection in preschool children [J]. Chinese Journal of Child Health Care, 2022, 30(3): 330-334.
[13]	TAO Feng-jiao, WEN Hang-wei, LIU Zuo-jiao. Relationship between serum high mobility group box-1 protein, soluble cluster differentiation 163 levels andfractional exhaled nitric oxide concentration and severity of bronchiolitis in children [J]. Chinese Journal of Child Health Care, 2022, 30(3): 335-338.
[14]	CHEN Xiang-fei, QU Shu-qiang. Research progress in biomarkers in the risk of bronchopulmonary dysplasia [J]. Chinese Journal of Child Health Care, 2022, 30(2): 176-180.
[15]	SHEN Ren, YANG Shan-pu, WU Yue-chao, ZHOU Yan, ZHANG Lin-tao. Expression and clinical significance of serum microRNA-155 in children with recurrent wheezing [J]. Chinese Journal of Child Health Care, 2021, 29(11): 1253-1256.